Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...

Precision BioSciences Inc. (NASDAQ:DTIL) presented new preclinical findings for its PBGENE-DMD gene therapy at the Muscular ...

"Fast Track designation is an important regulatory milestone for PBGENE-DMD and reflects the significant unmet need in DMD," said Michael Amoroso, Chief Executive Officer of Precision BioSciences. "We ...

RIPPLE™ (Remote Induction of Pulsed Pressure Lateral to Energy) is a proprietary ultrasound-mediated delivery ...

RIPPLE(TM) (Remote Induction of Pulsed Pressure Lateral to Energy) is a proprietary ultrasound-mediated delivery technology. -- RIPPLE(TM) has been developed to enable efficient, redosable, targeted, ...

Abstract: In this paper we present a novel approach in multi-scale muscle modeling based on finite element method and Huxley crossbridge kinetics model. In order to determine the mechanical response ...

A finite element model of the cervical spine, including vertebrae, intervertebral discs, ligaments, and implants (cage and screws), was developed based on CT data from a healthy volunteer. Three ...

Abstract: In this paper, a novel prototype of a cable-driven prosthetic hand with biorealisitic muscle property was developed. A pair of antagonistic muscles controlled the flexion and extension of ...

Male C57BL/6J mice (4 months old) were assigned to ground control or hindlimb unloading (HU) groups under normoxia (21% O 2) or hypoxia (15% O 2) and treated daily with placebo or resveratrol (20 or ...